Eduard Parellada, MD, MSc, PhD: Long-Acting Injectable Risperidone in the Treatment of Schizophrenia in Special Patient Populations

Name: Eduard Parellada, MD, MSc, PhD: Long-Acting Injectable Risperidone in the Treatment of Schizophrenia in Special Patient Populations
SKU: 2766
Availability: InStock

$30.00

Want a discount? Become a member by purchasing Psychopharmacology Bulletin Subscription - Individual!

Categories: Psychopharmacology Bulletin, VOL 40 No. 2 Articles Tags: eduard-parellada, ethnicityrace, health-disparities, illness-characteristics, ipolar-disorder, md, msc, phd

Description

Eduard Parellada, MD, MSc, PhD: Long-Acting Injectable Risperidone in the Treatment of Schizophrenia in Special Patient Populations

Description

Eduard Parellada, MD, MSc, PhD

DRUG DISPOSITION & PHARMACOKINETICS

Long-Acting Injectable Risperidone in the Treatment of Schizophrenia in Special Patient Populations

Eduard Parellada, MD, MSc, PhD

Johannes Hamann, MD: How Long do Psychiatrists Wait for Response Before They Switch to Another Antipsychotic?

P. Murali Doraiswamy, MD: Donepezil for Cognitive Decline Following Coronary Artery Bypass Surgery: A Pilot Randomized Controlled Trial

David V. Sheehan, MD, MBA: The Speed of Onset of Action of Alprazolam-XR Compared to Alprazolam-CT in Panic Disorder

Eduard Parellada, MD, MSc, PhD: Long-Acting Injectable Risperidone in the Treatment of Schizophrenia in Special Patient Populations

Description

Eduard Parellada, MD, MSc, PhD

DRUG DISPOSITION & PHARMACOKINETICS

Long-Acting Injectable Risperidone in the Treatment of Schizophrenia in Special Patient Populations

Eduard Parellada, MD, MSc, PhD

Related products

Johannes Hamann, MD: How Long do Psychiatrists Wait for Response Before They Switch to Another Antipsychotic?

P. Murali Doraiswamy, MD: Donepezil for Cognitive Decline Following Coronary Artery Bypass Surgery: A Pilot Randomized Controlled Trial

David V. Sheehan, MD, MBA: The Speed of Onset of Action of Alprazolam-XR Compared to Alprazolam-CT in Panic Disorder

Ethical Issues In Schizophrenia: Considerations for Treatment and Research